Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome. [PDF]
Sun X +11 more
europepmc +1 more source
Molecular detection of Shiga toxin-producing <i>Escherichia coli</i> in wild rats from urban areas of Banyuwangi District, Indonesia: Implications for zoonotic risk and public health. [PDF]
Praja RN +14 more
europepmc +1 more source
Intestinal tissue response to Shiga toxin exposure. [PDF]
Hanson KL, Weiss AA.
europepmc +1 more source
Long-term impacts of untreated dairy manure on the microbiome and Shiga toxin-producing <i>Escherichia coli</i> persistence in agricultural soil. [PDF]
Richter TKS +5 more
europepmc +1 more source
Related searches:
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
Lancet, The, 2005Phillip I Tarr
exaly +2 more sources
Detection Methods for Shiga Toxins and Shiga Toxin-Producing E. coli
2017Shiga toxin detection methods reflect the complicated biological processes that deliver these toxins to their target cells. Some detection methods employ techniques that indirectly detect the presence of Shiga toxins. Microbiological methods are used to identify pathogenic serotypes of E. coli, such as the infamous O157:H7, but the potential production
Christopher J. Silva +3 more
openaire +2 more sources
Nanobody-Based Bispecific Neutralizer for Shiga Toxin-Producing E. coli.
ACS Infectious Diseases, 2022Currently, no specific therapeutics are available for foodborne Shiga toxin-producing Escherichia coli (STEC) infections that cause severe gastroenteritis and life-threatening complications of hemolytic uremic syndrome (HUS).
Zhongkai Lu +8 more
semanticscholar +1 more source
Shiga toxins are virulence factors produced by the bacteria Shigella dysenteriae and certain strains of Escherichia coli. There is currently no available treatment for disease caused by these toxin-producing bacteria, and understanding the biology of the Shiga toxins might be instrumental in addressing this issue.
Jonas, Bergan +4 more
openaire +2 more sources
Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant.
Clinical Infectious Diseases, 2020Fecal microbiota transplantation (FMT) is recommended therapy for multiply recurrent Clostridioides difficile infection. We report adverse events in 7 patients who received FMT from a stool donor who was colonized with Shiga toxin-producing Escherichia ...
Caroline Zellmer +5 more
semanticscholar +1 more source

